Skip to main content

Table 3 IgE percentage reduction during VIT related to field sting

From: Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

YJ-IgE levels (kUA/L) Group Mean ± SD Min Max Mean percentage reduction (%)
CAP0–CAP3 NoS 3.81 ± 5.13 0.01 27.59 48.2
SP 0–3 2.61 ± 3.53 0.00 21.22 30.7
SP 3–5 4.75 ± 5.32 0.00 25.07 53.7
CAP3–CAP5 NoS 0.97 ± 1.60 0.00 11.97 37.1
SP 0–3 2.68 ± 4.13 0.00 20.97 50.3
SP 3–5 0.82 ± 1.03 0.00 6.40 17.0
CAP0–CAP5 NoS 4.39 ± 5.48 0.00 27.54 68.6
SP 0–3 5.15 ± 6.16 0.00 30.87 70.5
SP 3–5 5.24 ± 5.55 0.12 25.30 57.7
  1. Absolute (mean ± standard deviation SD, minimum and maximum) and percentage reductions of CAP values by group (NoS not stung, SP 0–3 stung and protected within the first 3 years of VIT, SP 3–5 stung and protected in the last 2 years of VIT)